1. Home
  2. ME
  3. ME News

Latest 23andMe Holding Co. (ME) News on March 14, 2025

ME

GuruFocus.com

4 days ago

23andMe's Wild Ride: From $6 Billion to Wojcicki's Buyout Gamble--Will Investors Get Screwed?

ME

MT Newswires

10 days ago

23andMe Rejects CEO's New Acquisition Proposal

23andMe Rejects CEO’s Takeover Bid of 41 Cents a Share
ME

The Wall Street Journal

11 days ago

23andMe Rejects CEO’s Takeover Bid of 41 Cents a Share

23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki
ME

GlobeNewswire

11 days ago

23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki

A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
ME

Fortune

13 days ago

A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million

23andMe Launches New Genetic Report on Osteoporosis
ME

GlobeNewswire

a month ago

23andMe Launches New Genetic Report on Osteoporosis

Trump's Medicaid freeze, Ozempic for kidney disease, and 23andMe for sale: Pharma news roundup
ME

Quartz

a month ago

Trump's Medicaid freeze, Ozempic for kidney disease, and 23andMe for sale: Pharma news roundup

23andMe considers sale as cash runs low
ME

MedTech Dive

a month ago

23andMe considers sale as cash runs low

23andMe weighing up sale of the company as cash runs dry
ME

Medical Device Network

a month ago

23andMe weighing up sale of the company as cash runs dry

23andMe Board Explores Strategic Alternatives Amid Restructuring
ME

GuruFocus.com

a month ago

23andMe Board Explores Strategic Alternatives Amid Restructuring

23andMe might sell itself as it runs out of money
ME

Quartz

a month ago

23andMe might sell itself as it runs out of money

ME

MT Newswires

a month ago

23andMe Holding Begins Exploring Strategic Alternatives

23andMe Special Committee Announces Exploration of Strategic Alternatives
ME

GlobeNewswire

a month ago

23andMe Special Committee Announces Exploration of Strategic Alternatives

23andMe Reports Third Quarter Fiscal Year 2025 Financial Results
ME

GlobeNewswire

a month ago

23andMe Reports Third Quarter Fiscal Year 2025 Financial Results

23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology
ME

GlobeNewswire

2 months ago

23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology

3 Promising US Penny Stocks With Over $9M Market Cap
ME

Simply Wall St.

2 months ago

3 Promising US Penny Stocks With Over $9M Market Cap

What’s Next for 23andMe?
ME

Pharma Voice

3 months ago

What’s Next for 23andMe?

US Penny Stocks: 3 Picks With Market Caps Under $200M
ME

Simply Wall St.

3 months ago

US Penny Stocks: 3 Picks With Market Caps Under $200M

Do Redditors Think That 23andMe Holding Co. (ME) Has a Big Upside Potential?
ME

Insider Monkey

4 months ago

Do Redditors Think That 23andMe Holding Co. (ME) Has a Big Upside Potential?

ME

MT Newswires

4 months ago

23andMe, Mirador Therapeutics Collaborate on Target Validation, Precision Medicine

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
ME

GlobeNewswire

4 months ago

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation

23andMe to lay off more than 200 employees amid business struggles
ME

MedTech Dive

4 months ago

23andMe to lay off more than 200 employees amid business struggles

ME

GuruFocus.com

4 months ago

23andMe Holding Co (ME) Q2 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...

ME

Thomson Reuters StreetEvents

4 months ago

Q2 2024 23andMe Holding Co. Earnings Call

23andMe is falling apart
ME

Quartz

4 months ago

23andMe is falling apart

23andMe cuts 40% of its workforce
ME

Fox Business

4 months ago

23andMe cuts 40% of its workforce

Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
ME

Benzinga

4 months ago

Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs

After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health
ME

Fortune

4 months ago

After its entire board resigned overnight, 23andMe will cut over 200 employees and its cancer research in an urgent bid to nurse the company back to health

23andMe cuts 40% of its workforce and discontinues therapeutics division
ME

Associated Press Finance

4 months ago

23andMe cuts 40% of its workforce and discontinues therapeutics division

What’s happening with 23andMe? Mass layoffs and restructuring are the latest blow for the embattled DNA-testing company
ME

FastCompany

4 months ago

What’s happening with 23andMe? Mass layoffs and restructuring are the latest blow for the embattled DNA-testing company

23andMe Lays Off 40% of Staff, Shuts Drug Development Business
ME

The Wall Street Journal

4 months ago

23andMe Lays Off 40% of Staff, Shuts Drug Development Business

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results
ME

GlobeNewswire

4 months ago

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

23andMe cuts 40% of its workforce, discontinues all therapy programs
ME

CNN Business

4 months ago

23andMe cuts 40% of its workforce, discontinues all therapy programs

ME

MT Newswires

4 months ago

23andMe to Cut 40% of Workforce to Reduce Expenses, Examine Options for Assets

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
ME

GlobeNewswire

4 months ago

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
ME

GlobeNewswire

4 months ago

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

23andMe to Report Q2 FY2025 Financial Results
ME

GlobeNewswire

4 months ago

23andMe to Report Q2 FY2025 Financial Results

23andMe turns to CFOs to fill director roles after mass board exit
ME

CFO Dive

4 months ago

23andMe turns to CFOs to fill director roles after mass board exit

23andMe appoints three former CFOs as new directors—after the previous board all resigned
ME

Fortune

4 months ago

23andMe appoints three former CFOs as new directors—after the previous board all resigned

23andMe Regains Compliance With Nasdaq Listing Requirements
ME

GlobeNewswire

4 months ago

23andMe Regains Compliance With Nasdaq Listing Requirements

23andMe Appoints Three New Independent Directors to Board
ME

GlobeNewswire

4 months ago

23andMe Appoints Three New Independent Directors to Board

Ancestry Says a 23AndMe Takeover Would Raise Antitrust Issues
ME

Bloomberg

4 months ago

Ancestry Says a 23AndMe Takeover Would Raise Antitrust Issues

Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundup
ME

Quartz

5 months ago

Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundup

The crisis at 23andMe, explained
ME

Quartz

5 months ago

The crisis at 23andMe, explained

ASML's Latest Chapter in the Semiconductor Story
ME

Motley Fool

5 months ago

ASML's Latest Chapter in the Semiconductor Story

SC US (TTGP), LTD. Acquires New Stake in 23andMe Holding Co
ME

GuruFocus.com

5 months ago

SC US (TTGP), LTD. Acquires New Stake in 23andMe Holding Co

Explainer: 23andme is about to collapse – what happens to all that DNA data?
ME

Medical Device Network

5 months ago

Explainer: 23andme is about to collapse – what happens to all that DNA data?

23andMe CEO says she can 'land this plane' after the entire board resigns
ME

Quartz

5 months ago

23andMe CEO says she can 'land this plane' after the entire board resigns

Behind the scenes at 23andMe, questions about a star CEO
ME

Fortune

5 months ago

Behind the scenes at 23andMe, questions about a star CEO

23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South
ME

GlobeNewswire

5 months ago

23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South

23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable
ME

Fortune

5 months ago

23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable

23andMe Announces Completion of 1-for-20 Reverse Stock Split
ME

GlobeNewswire

5 months ago

23andMe Announces Completion of 1-for-20 Reverse Stock Split

ME

Financial Times

5 months ago

Founder Anne Wojcicki races to rescue 23andMe

ME

MT Newswires

5 months ago

23andMe Announces 1-for-20 Reverse Stock Split

23andMe Announces Mathew Knowles as New Brand Ambassador
ME

GlobeNewswire

5 months ago

23andMe Announces Mathew Knowles as New Brand Ambassador

Millions urged to delete data from mail-order DNA test maker
ME

The Telegraph

5 months ago

Millions urged to delete data from mail-order DNA test maker

Here’s how to delete your data from 23andMe if you’re worried about protecting your personal health information
ME

Fortune

5 months ago

Here’s how to delete your data from 23andMe if you’re worried about protecting your personal health information

Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants
ME

Benzinga

5 months ago

Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants

ME

Investing.com

5 months ago

23andMe no longer open to third-party takeover bids - filing

23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows
ME

Reuters

5 months ago

23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows

23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating
ME

GlobeNewswire

6 months ago

23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating

23andMe Board Quits As CEO Of DNA Testing Company Plans To Go Private
ME

Black Enterprise

6 months ago

23andMe Board Quits As CEO Of DNA Testing Company Plans To Go Private

What happened to 23andMe?
ME

CNN Business

6 months ago

What happened to 23andMe?

23andMe directors resign as the CEO of the genetic-testing company seeks to take it private
ME

Associated Press Finance

6 months ago

23andMe directors resign as the CEO of the genetic-testing company seeks to take it private

How 23andMe Went From Market Darling to Losing Its Entire Board
ME

Barrons.com

6 months ago

How 23andMe Went From Market Darling to Losing Its Entire Board

23andMe’s independent board directors resign
ME

MedTech Dive

6 months ago

23andMe’s independent board directors resign

Every single member of the board just resigned from DNA tester 23andMe
ME

Fortune

6 months ago

Every single member of the board just resigned from DNA tester 23andMe

Tupperware, UAW-Stellantis, 23andme: 3 Stories In Focus
ME

Yahoo Finance Video

6 months ago

Tupperware, UAW-Stellantis, 23andme: 3 Stories In Focus

ME

MT Newswires

6 months ago

Sector Update: Health Care Stocks Steady Premarket Wednesday

Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time
ME

Benzinga

6 months ago

Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time

ME

MT Newswires

6 months ago

Market Chatter: 23andMe's Independent Directors Resign Over Weak Take-Private Offer

ME

Investing.com

6 months ago

Landmark Fed decision in focus, futures edge higher - what's moving markets

23andMe Board Resigns in New Blow to DNA-Testing Company
ME

The Wall Street Journal

6 months ago

23andMe Board Resigns in New Blow to DNA-Testing Company

23andMe independent directors quit board over unsatisfactory buyout plan from CEO
ME

Reuters

6 months ago

23andMe independent directors quit board over unsatisfactory buyout plan from CEO

Independent Directors of 23andMe Resign from Board
ME

GlobeNewswire

6 months ago

Independent Directors of 23andMe Resign from Board

23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial
ME

GlobeNewswire

6 months ago

23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial

23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study
ME

GlobeNewswire

6 months ago

23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study

23andMe settles data breach lawsuit for $30 million
ME

Reuters

6 months ago

23andMe settles data breach lawsuit for $30 million

One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations
ME

GlobeNewswire

6 months ago

One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations

23andMe CEO Wojcicki open to third-party takeover proposals for firm, filing shows
ME

Reuters

6 months ago

23andMe CEO Wojcicki open to third-party takeover proposals for firm, filing shows

ME

MT Newswires

6 months ago

23andMe Holding Investor Anne Wojcicki Open to Weighing Takeover Proposals

23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024
ME

GlobeNewswire

6 months ago

23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024

ME

MT Newswires

6 months ago

23andMe Holding's Subsidiary Offering Obesity Drugs Through Subscription-Based Weight Loss Program

Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
ME

GlobeNewswire

7 months ago

Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program

23andMe Reports First Quarter Fiscal 2025 Financial Results
ME

GlobeNewswire

7 months ago

23andMe Reports First Quarter Fiscal 2025 Financial Results

ME

MT Newswires

7 months ago

23andMe Rejects CEO's Take-Private Proposal

23andMe board rejects CEO Wojcicki’s take-private proposal
ME

MedTech Dive

7 months ago

23andMe board rejects CEO Wojcicki’s take-private proposal

Genetic testing firm 23andMe rejects CEO's take-private offer
ME

Reuters

7 months ago

Genetic testing firm 23andMe rejects CEO's take-private offer

Genetic testing firm 23andMe rejects CEO's take-private offer
ME

Reuters

7 months ago

Genetic testing firm 23andMe rejects CEO's take-private offer

23andMe Special Committee responds to CEO’s take-private proposal
ME

GlobeNewswire

7 months ago

23andMe Special Committee responds to CEO’s take-private proposal

ME

MT Newswires

7 months ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

ME

MT Newswires

7 months ago

23andMe Receives Take-Private Proposal from Chief Executive

23andMe CEO proposes to take company private
ME

MedTech Dive

7 months ago

23andMe CEO proposes to take company private

23andMe Announces CEO’s Take-Private Proposal
ME

GlobeNewswire

7 months ago

23andMe Announces CEO’s Take-Private Proposal

23andMe CEO Wojcicki makes offer to take the firm private, filing shows
ME

Reuters

7 months ago

23andMe CEO Wojcicki makes offer to take the firm private, filing shows

23andMe to Report Q1 FY2025 Financial Results
ME

GlobeNewswire

8 months ago

23andMe to Report Q1 FY2025 Financial Results

Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research
ME

GlobeNewswire

8 months ago

Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research

23andMe and Nightingale partner to pilot blood-based risk detection panel
ME

Medical Device Network

8 months ago

23andMe and Nightingale partner to pilot blood-based risk detection panel

ME

MT Newswires

8 months ago

23andMe to Offer Free Blood Testing for Members in Pilot Program

23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
ME

GlobeNewswire

9 months ago

23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel

Share on Social Networks: